Evgeny A. Usynin

Evgeny A. Usynin

Auto-generated profile, based on publicly available information

Evgeny A. Usynin

Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2020 in Cells
Verified
Journal Article
Open access
PDF file
LSLuidmila Spirina
Luidmila Spirina
ZYZahar A. Yurmazov
Zahar A. Yurmazov
AGAlexey K. Gorbunov
Alexey K. Gorbunov
EUEvgeny A. Usynin
Evgeny A. Usynin
NLNadejda Lushnikova
Nadejda Lushnikova
IKIrina Kovaleva
Irina Kovaleva
Metastasis involves the spread of cancer cells from the primary tumor to surrounding tissues and distant organs and is the primary cause of cancer morbidity and mortality. The aim of the study was the determination of change in molecular factors expression in primary kidney cancers (ccRCC) and metastatic sites. In total, 62 patients with RCC were enrolled in the study. The mRNA levels of molecular markers were studied by real-time PCR, and the content of the studied parameters was determined by Western blotting and ELISA. The features in the intracellular signal metabolites in the series of normal renal parenchyma, tumor tissue of localized, disseminated kidney cancer and metastatic tissue were studied. A decrease in some indicators in the tissue of the metastatic lesion was noted. Protein products of transcription factors HIF-1, CAIX, PTEN and activated AKT kinase, as well as expression of the VEGFR2 receptor and m-TOR protein kinase were revealed to be reduced in the metastatic sites. In addition, some indicators increased in metastasis: the protein levels of NF-κB p 50, NF-κB p 65, HIF-2, VEGF, VEGFR2, m-TOR and mRNA of HIF-1, CAIX, PTEN and PDK. There were indicators with multidirectional changes. HIF-1, CAIX, PTEN, VEGFR2 and m-TOR mRNA: VEGFR2, m-TOR, HIF-1, CAIX, PTEN and PDK had an opposite change in protein content and mRNA level. PTEN loss resulted in the downstream activation of AKT/mTOR signaling in secondary cancer lesions and determined the overall ccRCC patient’s survival. The AKT/mTOR signaling cascade activation was found in the primary kidney tumors. The PTEN content and mRNA level were correlated with total AKT, GSK-3β, the 70S 6 kinases and AKT expression.

3 March 2018 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
LSLuidmila Spirina
Luidmila Spirina
AGA. K. Gorbunov
A. K. Gorbunov
IKIrina V. Kondakova
Irina V. Kondakova
ESE. M. Slonimskaya
E. M. Slonimskaya
EUE. A. Usynin
E. A. Usynin
Введение. Транскрипционные факторы POU4F1 (нейрогенные факторы Brn-3α) играют значимую роль в развитии злокачественных новообразований. Цель исследования – изучение экспрессии транскрипционного фактора Brn-3α, андрогеновых (AR) и эстрогеновых рецепторов (ER) в ткани доброкачественной гиперплазии и рака предстательной железы и определении связи с уровнем активации AKT/mTOR сигнального пути. Материал и методы. В исследование было включено 30 больных местнораспространенным раком предстательной железы (РПЖ) T2–3N0M0, 15 пациентов с доброкачественной гиперплазией предстательной железы (ДГПЖ). Определение уровня экспрессии генов Brn-3α, AR, ERα, а также компонентов AKT/m-TOR сигнального пути проводилось методом ПЦР в реальном времени. Результаты. Показано, что увеличение экспрессии гена ядерного белка Brn-3α сопровождалось ростом уровня мРНК ERα в ткани рака предстательной железы. Экспрессия AR была высока в обеих группах больных. Выявлена активация AKT/m-TOR сигнального каскада: отмечены высокие уровни экспрессии AKT, а также m-TOR в трансформированных клетках. Однако отмечено отсутствие изменений фосфатазы PTEN при развитии патологических процессов предстательной железы. Заключение. Транскрипционный фактор Brn-3α связан с развитием РПЖ, что сопровождается повышением экспрессии ERα, протеинкиназы AKT и m-TOR.

1 January 2019 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
SASergey G. Afanasyev
Sergey G. Afanasyev
ADAlexey Dobrodeev
Alexey Dobrodeev
IKI. B. Khadagaev
I. B. Khadagaev
SFS. A. Fursov
S. A. Fursov
EUE. A. Usynin
E. A. Usynin
БФБ. Б. Фальтин
Б. Б. Фальтин
Background.Currently, the indications for multivisceral pelvic resections have increased dramatically. However, short-and long-term outcomes after these resections for locally advanced rectal cancer remain a subject of debate.The purposeof the study was to evaluate short-term surgical and oncological outcomes after multivisceral pelvic resections in patients with locally advanced rectal cancer.Material and methods. We analyzed surgical outcomes in 32 patients (13 men and 19 women) aged 44-69 years, with locally advanced rectal cancer, who were treated between 2010 and 2016. Of the 32 patients, 28 (87.5 %) had rectal cancer with invasion into adjacent organs (posterior wall of the bladder - 13, uterus - 10, ureters - 5, prostate - 4, vagina - 3; simultaneous damage to more than 2 organs - 14, multiple primary malignant tumors: rectal cancer + bladder cancer - 2, rectal cancer + endometrial cancer - 1, rectal cancer + rectal GIST - 1.Results.Total pelvic evisceration was performed in 6 (18.8 %) cases, combined resection of the rectum and adjacent organs was performed in 26 (81.2 %). Urinary tract resection was performed in 24 (75.0 %) patients. Of these patients, 13 (40.6 %) had primary plasty of the bladder and/or ureters. Postoperative surgical complications were observed in 11 (34.4 %) patients, of whom 7 (21.8 %) patients needed re-surgery. In 1 patient (3.1 %), who died in the early postoperative period, the cause of death was thrombosis of the right iliac vessels with subsequent acute renal failure. For patients with locally advanced rectal cancer, long-term outcomes were as follows: the overall and recurrence-free 2-year survival rates were 75 % and 56.3 %, respectively. All patients with multiple primary malignant tumors were alive with no evidence of disease recurrence at a follow-up of >24 months.Conclusion.Multivisceral resection in patients with locally advanced rectal cancer is a complex surgical procedure requiring the multidisciplinary team of surgeons. Despite high operative morbidity, proper perioperative management of the patients helps to achieve satisfactory immediate treatment outcomes. Long-term outcomes allowed us to consider such resections as a method of choice for locally advanced and multiple primary rectal cancers.

1 January 2016 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
LSLuidmila Spirina
Luidmila Spirina
YUY. A. Usynin
Y. A. Usynin
IKIrina V. Kondakova
Irina V. Kondakova
ZYZ. A. Yurmazov
Z. A. Yurmazov
ESE. M. Slonimskaya
E. M. Slonimskaya
LPL. V. Pikalova
L. V. Pikalova
The investigation of molecular mechanisms of tumor cell behavior in small renal masses is required to achieve the better cancer survival. The aim of the study is to find molecular markers associated with outcome of patients with kidney tumors 7 cm or less. A homogenous group of 20 patients T1N0M0-1 (mean age 57.6 ± 2.2 years) with kidney cancer was selected for the present analysis. The content of transcription and growth factors was determined by ELISA. The levels of AKT-mTOR signaling pathway components were measured by Western blotting analysis. The molecular markers associated with unfavorable outcome of patients with kidney tumors 7 cm or less were high levels of NF-kB p50, NF-kB p65, HIF-1, HIF-2, VEGF and CAIX. AKT activation with PTEN loss also correlated with the unfavorable outcome of kidney cancer patients with tumor size 7 cm or less. It is observed that the biological features of kidney cancer could predict the outcome of patients.